N-(2-Chloro-pyrimidin-4-yl)-N,2-di-methyl-2H-indazol-6-amine.

Acta Crystallogr Sect E Struct Rep Online

Published: October 2010

In the title compound, C(13)H(12)ClN(5), which is a derivative of the anti-tumor agent pazopanib {systematic name: 5-[[4-[(2,3-di-methyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}, the indazole and pyrim-idine fragments form a dihedral angle of 62.63 (5)°. In the crystal, pairs of mol-ecules related by twofold rotational symmetry are linked into dimers through π-π inter-actions between the indazole ring systems [centroid-centroid distance = 3.720 (2) Å]. Weak inter-molecular C-H⋯N hydrogen bonds further assemble these dimers into columns propagated in [001].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009102PMC
http://dx.doi.org/10.1107/S1600536810042753DOI Listing

Publication Analysis

Top Keywords

n-2-chloro-pyrimidin-4-yl-n2-di-methyl-2h-indazol-6-amine title
4
title compound
4
compound c13h12cln5
4
c13h12cln5 derivative
4
derivative anti-tumor
4
anti-tumor agent
4
agent pazopanib
4
pazopanib {systematic
4
{systematic 5-[[4-[23-di-methyl-2h-indazol-6-ylmethylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}
4
5-[[4-[23-di-methyl-2h-indazol-6-ylmethylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide} indazole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!